781 related articles for article (PubMed ID: 25839899)
1. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
[TBL] [Abstract][Full Text] [Related]
2. Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.
Klein S; Bankstahl M; Löscher W
Neuropharmacology; 2015 Mar; 90():53-62. PubMed ID: 25460186
[TBL] [Abstract][Full Text] [Related]
3. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
[TBL] [Abstract][Full Text] [Related]
4. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
5. AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives.
Di Bonaventura C; Labate A; Maschio M; Meletti S; Russo E
Expert Opin Pharmacother; 2017 Nov; 18(16):1751-1764. PubMed ID: 29023170
[TBL] [Abstract][Full Text] [Related]
6. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.
Namba T; Morimoto K; Sato K; Yamada N; Kuroda S
Brain Res; 1994 Feb; 638(1-2):36-44. PubMed ID: 8199874
[TBL] [Abstract][Full Text] [Related]
8. The immunosuppressant cyclosporin A inhibits recurrent seizures in an experimental model of temporal lobe epilepsy.
Jung S; Yang H; Kim BS; Chu K; Lee SK; Jeon D
Neurosci Lett; 2012 Nov; 529(2):133-8. PubMed ID: 22981977
[TBL] [Abstract][Full Text] [Related]
9. Various modifications of the intrahippocampal kainate model of mesial temporal lobe epilepsy in rats fail to resolve the marked rat-to-mouse differences in type and frequency of spontaneous seizures in this model.
Klee R; Brandt C; Töllner K; Löscher W
Epilepsy Behav; 2017 Mar; 68():129-140. PubMed ID: 28167446
[TBL] [Abstract][Full Text] [Related]
10. A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsy.
Schidlitzki A; Twele F; Klee R; Waltl I; Römermann K; Bröer S; Meller S; Gerhauser I; Rankovic V; Li D; Brandt C; Bankstahl M; Töllner K; Löscher W
Sci Rep; 2017 Sep; 7(1):12191. PubMed ID: 28939854
[TBL] [Abstract][Full Text] [Related]
11. AMPA Receptor Antagonist NBQX Decreased Seizures by Normalization of Perineuronal Nets.
Chen W; Li YS; Gao J; Lin XY; Li XH
PLoS One; 2016; 11(11):e0166672. PubMed ID: 27880801
[TBL] [Abstract][Full Text] [Related]
12. Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
Zwart R; Sher E; Ping X; Jin X; Sims JR; Chappell AS; Gleason SD; Hahn PJ; Gardinier K; Gernert DL; Hobbs J; Smith JL; Valli SN; Witkin JM
J Pharmacol Exp Ther; 2014 Oct; 351(1):124-33. PubMed ID: 25027316
[TBL] [Abstract][Full Text] [Related]
13. AMPA receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures.
Lippman-Bell JJ; Rakhade SN; Klein PM; Obeid M; Jackson MC; Joseph A; Jensen FE
Epilepsia; 2013 Nov; 54(11):1922-32. PubMed ID: 24117347
[TBL] [Abstract][Full Text] [Related]
14. A face-to-face comparison of the intra-amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapies.
Welzel L; Schidlitzki A; Twele F; Anjum M; Löscher W
Epilepsia; 2020 Jan; 61(1):157-170. PubMed ID: 31828786
[TBL] [Abstract][Full Text] [Related]
15. The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats.
Rattka M; Brandt C; Löscher W
Epilepsy Res; 2013 Feb; 103(2-3):135-52. PubMed ID: 23196211
[TBL] [Abstract][Full Text] [Related]
16. A guinea pig model of mesial temporal lobe epilepsy following nonconvulsive status epilepticus induced by unilateral intrahippocampal injection of kainic acid.
Carriero G; Arcieri S; Cattalini A; Corsi L; Gnatkovsky V; de Curtis M
Epilepsia; 2012 Nov; 53(11):1917-27. PubMed ID: 22998690
[TBL] [Abstract][Full Text] [Related]
17. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
Löscher W
Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
[TBL] [Abstract][Full Text] [Related]
18. Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy.
Riban V; Bouilleret V; Pham-Lê BT; Fritschy JM; Marescaux C; Depaulis A
Neuroscience; 2002; 112(1):101-11. PubMed ID: 12044475
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous recurrent seizures in an intra-amygdala kainate microinjection model of temporal lobe epilepsy are differentially sensitive to antiseizure drugs.
West PJ; Thomson K; Billingsley P; Pruess T; Rueda C; Saunders GW; Smith MD; Metcalf CS; Wilcox KS
Exp Neurol; 2022 Mar; 349():113954. PubMed ID: 34922908
[TBL] [Abstract][Full Text] [Related]
20. The discovery and development of perampanel for the treatment of epilepsy.
Hanada T
Expert Opin Drug Discov; 2014 Apr; 9(4):449-58. PubMed ID: 24559052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
